Table 5.
Univariate and multivariate analysis of the association between sub-categories of various receptors and overall survival. A p-value of <0.05 was considered significant. Overall survival relative to the indicated features was determined by Cox regression analysis.
| Expression in Years | Univariate | Multivariate | ||||
|---|---|---|---|---|---|---|
| Hazard Ratio |
95% CI | p-Value | Hazard Ratio | 95% CI | p-Value | |
| HER2 Intensity 1+ | 0.665 | 0.398–1.111 | 0.119 | 0.677 | 0.403–1.137 | 0.140 |
| HER2 ≥ 5% | 0.567 | 0.331–0.970 | 0.038 | 0.556 | 0.323–0.958 | 0.034 |
| HER2 ≥ 50% | 0.608 | 0.332–1.114 | 0.107 | 1.37 | 0.910–2.081 | 0.130 |
| HER2 Cytoplasmic | 0.612 | 0.354–1.056 | 0.078 | 0.650 | 0.373–1.132 | 0.128 |
| HER2/HER4 ≥ 5% | 0.669 | 0.414–1.083 | 0.102 | 0.706 | 0.433–1.151 | 0.162 |
| HER2/EGFRVIII ≥ 5% | 0.670 | 0.413–1.089 | 0.106 | 0.710 | 0.435–1.158 | 0.170 |
| HER2/CD44 ≥ 5% | 0.669 | 0.398–1.122 | 0.128 | 0.687 | 0.405–1.164 | 0.163 |
| HER2/HER4/EGFRVIII ≥ 5% | 0.686 | 0.686–1.098 | 0.116 | 0.718 | 0.445–1.156 | 0.173 |
| HER2/HER4/EGFRVIII/CD44 ≥ 5% | 0.678 | 0.424–1.085 | 0.105 | 0.702 | 0.436–1.133 | 0.147 |